Listing p2

Listing p2 presents a rare opportunity to acquire a 150,000-square-foot, fully leased office asset ideally situated at test 123, New York, AK 123456. As a “Coming Soon” offering, this property delivers immediate cash flow through 100 percent occupancy, anchored by a diverse tenant roster spanning co-working, creative studios, executive suites, medical office and R&D/life science uses. Investors will benefit from a stabilized income stream in a market where demand for flexible, class-A workspace remains consistently strong.

Built to accommodate a variety of professional needs, the building’s floor plates are thoughtfully designed for efficient tenant fit-outs and can support both open-plan collaborative environments and specialized laboratory or clinical operations. State-of-the-art mechanical systems, ample parking and strategic visibility combine to enhance tenant retention and maintain high operating performance. Whether serving fast-growing startups, established creative agencies or medical practitioners, Listing p2 offers the adaptability that modern office users require.

Positioned as a core-plus investment, Listing p2 delivers a combination of stable in-place cash flow and compelling upside potential through market-rate lease renewals and repositioning opportunities. With detailed financial metrics available in the confidential offering memorandum, qualified investors are invited to contact the listing agent today to discuss pricing, cap-rate expectations and tailored acquisition strategies.